LAFAYETTE—Cardiovascular Institute of the South (CIS) is one of the first two sites in the United States to use the UltraScore™ Focused Force PTA Balloon to open a blocked artery during angioplasty. Dr. Amit Amin, interventional cardiologist at CIS, first used the device on March 28 at the office-based catheterization laboratory at CIS at 2730 Ambassador Caffery Parkway.
The UltraScore™ Focused Force PTA Balloon is indicated to treat stenotic lesions of the superficial femoral artery (SFA), popliteal artery, and infra-popliteal arteries. It is the first commercially available .035-inch scoring balloon on the U.S. market. The UltraScore™ provides concentrated force where the wires contact the lesion and is designed to longitudinally fracture plaque at lower inflation pressure compared to a standard balloon.
“This new technology is engineered to allow physicians to treat a stenotic lesion while potentially offering a lesser chance of tears in the inner layer of the artery,” explained Dr. Amit Amin. “For patients, this can offer a great alternative to a traditional balloon.”
CIS is participating in the Bard® UltraScore Study— a prospective, multi-center, single-arm, real-world study assessing the clinical use of the Bard® UltraScore™ Focused Force PTA balloon for the treatment of stenotic lesions of the superficial femoral artery (SFA), popliteal artery, and infra-popliteal arteries. Dr. Craig Walker, CIS founder, president and medical director, is the principal investigator of the study.
To learn more about CIS interventional cardiologists in Lafayette, call 337-988-1585.